Tag | Content |
---|
EnhancerAtlas ID | HS093-06470 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr12:1921640-1922670 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
HNF4G | MA0484.1 | chr12:1922201-1922216 | AAGGGTCAAAGGCCA | + | 6.85 | NR2C2 | MA0504.1 | chr12:1922201-1922216 | AAGGGTCAAAGGCCA | + | 6.19 | Nr2f6 | MA0677.1 | chr12:1922202-1922216 | AGGGTCAAAGGCCA | + | 6.26 | Rxra | MA0512.2 | chr12:1922202-1922216 | AGGGTCAAAGGCCA | + | 6.19 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr12 | 1921843 | 1922000 | chr12 | 1922000 | 1922400 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH12I001810 | chr12 | 1918961 | 1923200 |
|
Enhancer Sequence | AATAGAAAGA AGAGGCAGGT TATATTGAAA AGAAGAAGAA TTTCAAAACT AGGCCAGCTT 60 CCTAGTGTCT GGTATAATAA TATCAAAACT GCGCTGGGCG CTTAGAACGT GTCCAGCACC 120 TCACATGCAT GAGTGTATTG AATCCCACAG CAGGCCAGTC CTATTATTAT TCTGACTTTC 180 CAAGCTGAAG AAATGGAGAC TTTTCAGAGT CACATGGCTT GCCCAAGTCA CCAGCTTGTT 240 AATCACAGAA GCAGGACTGC AGCCTGGGCC TGTCTCTCCC TGAAGCTGCC TCCTCTCTGG 300 ACCTGGACTG AGTCCTGGTG ATCGGGAAGG AGCGGCGGGC ACAGGCAAGC CGCTGTCTGC 360 TCAGGCTCGG GTTTCCTCAT CTGTGAAACG GGAACGGATG TGGCTTCTTA ACCATTACGC 420 TGTGTCCGTC ACAGTCATTC TCACTTCTCG AGTACCCAGT TGGTGGGAGT TCCAGTATGG 480 CACAGAGATA CAGGATTGTG TTTTTGTTTT TTCACTCTGG AATGATCTTA GAGAAATTTG 540 ATGGGAAAAA TGAGAGCAGG GAAGGGTCAA AGGCCAGAGG TCCAGCCCTG CATTTTCCAG 600 GGTTGTGATC TTTGCGTTTC GTCTCCTCAG CTGCAAGATG AGTCACGGTT CTACTTCCCC 660 TGGAAGGGCA GAAGTTGCAT AAGATTGTTG AGGCTCAAGC GAGATAATGT GTGAGGCTGT 720 TACTCCAGAC TAGAGCCTTG ATTTTTAAAC TTCAGCGTGC ATCAGAATCG CCTGGAAGGT 780 TTGTTAGAAC CCCGCCCCCA GAGTTTCTCC TTCAGGGGGT CCAGGGTGGG CCTGAGAGTT 840 TCTGAAGTGT TCCCAGGGGT TGCCGATGCT GCTAGTCCAG GCACTATATT TAGGGAACCC 900 CCGTCCTAAA GCCTCACCAA TTGAATCTCC TAAGATGATG AAGATGGCCT ACATCTGTGC 960 TGTCCTAAAC GGTAGCCAAC AGCCACACGT GGCTACTGAG AACTCGGAGT GTGGCTAGCA 1020 CGCCTGAGGA 1030
|